BioVigil Revenue and Competitors
Estimated Revenue & Valuation
- BioVigil's estimated annual revenue is currently $3.5M per year.
- BioVigil's estimated revenue per employee is $134,615
Employee Data
- BioVigil has 26 Employees.
- BioVigil grew their employee count by 73% last year.
BioVigil's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO | Reveal Email/Phone |
2 | VP Client Services | Reveal Email/Phone |
3 | VP Sales | Reveal Email/Phone |
4 | Head Finance | Reveal Email/Phone |
5 | VP - Finance and HR | Reveal Email/Phone |
6 | Marketing Director | Reveal Email/Phone |
7 | Chief Revenue Officer | Reveal Email/Phone |
8 | Director Engineering and Technology | Reveal Email/Phone |
9 | Director Installation | Reveal Email/Phone |
10 | Senior Director Operations | Reveal Email/Phone |
BioVigil Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $3.5M | 99 | 24% | N/A | N/A |
#2 | N/A | 107 | 7% | N/A | N/A |
#3 | N/A | 78 | 15% | N/A | N/A |
#4 | N/A | 18 | 0% | N/A | N/A |
#5 | N/A | 107 | 7% | N/A | N/A |
#6 | $35M | 160 | 23% | N/A | N/A |
#7 | N/A | 119 | 19% | N/A | N/A |
#8 | N/A | 39 | 56% | N/A | N/A |
#9 | N/A | 35 | 30% | N/A | N/A |
#10 | $3.5M | 123 | 28% | N/A | N/A |
What Is BioVigil?
Healthcare Associated Infections (HAIs) in hospitals are one of the Top 10 leading causes of death in the United States, accounting for over 75,000 preventable deaths each year. Our mission is to provide superior infection control and disease mitigation solutions that enhance patient care environments. In doing this, BioVigil improves Patient Safety, Quality of Care and Hospital Bottom Lines.
keywords:N/AN/A
Total Funding
26
Number of Employees
$3.5M
Revenue (est)
73%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $4.4M | 26 | -28% | N/A |
#2 | N/A | 26 | -10% | N/A |
#3 | $2.6M | 26 | 18% | N/A |
#4 | $1.9M | 26 | -26% | N/A |
#5 | $4.9M | 26 | 4% | N/A |